To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Propel exits herbal health product company
The Australian private equity firm has good news for investors as it raises its third fund booking a 2.5x cash return on its investment in MediHerb.
